Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab, Ipilimumab, and Aspirin in Melanoma
NCT03396952Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2018
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in melanoma, sponsored by University of California, San Francisco. Started Apr 2018; status: completed.
02
Drugs
aspirin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT03396952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03396952.